Prevention & Chronic Conditions

Broadcast

e-SPACE CRM 2026 – Day Two

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

Broadcast

e-SPACE CRM 2026 – Day One

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Articles

Gaps in Modern Heart Failure and Chronic Kidney Disease Research

Published:

23 August 2023

Citation:

European Cardiology Review 2023;18:e51.

Self-care Assessments and Practices in Older Patients with Heart Failure

Published:

16 June 2023

Citation:

Journal of Asian Pacific Society of Cardiology 2023;2:e21.

Timing of SGLT2 Inhibitors in Heart Failure

Published:

07 June 2023

Citation:

European Cardiology Review 2023;18:e41.

Effects of S/V Therapy on Exercise Capacity in Patients with HFrEF

Published:

19 May 2023

Citation:

Cardiac Failure Review 2023;8:e07.